(Press-News.org) DALLAS – Feb. 15, 2011 – Breast-cancer patient Kristin Wiginton is the first to be treated at UT Southwestern Medical Center with high-beam radiation using the Accuray CyberKnife System, which offers improved cosmetic results, less radiation exposure to surrounding tissue and a shorter treatment period.
Dr. Wiginton is among 45 participants in a UT Southwestern-based clinical trial – the first of its kind in the Southwest – investigating use of the radiation delivery system for breast cancer. Her post-lumpectomy therapy lasted one-third the duration of a typical radiation session for a breast-cancer patient.
While CyberKnife has been used at UT Southwestern since 1997, it primarily has been targeted for tumors of the brain and spine.
"If this had not worked out for me, I would have gone with six and a half weeks of traditional radiation," said Dr. Wiginton, 45, an associate professor of health studies at Texas Woman's University.
Instead, her treatment took less than two weeks and consisted of five 90-minute sessions every two to three days. Her final treatment was Feb. 3 at UT Southwestern University Hospital - Zale Lipshy.
Radiation therapy following a lumpectomy is commonly recommended to remove potential residual cancer, said Dr. Robert Timmerman, professor of radiation oncology and neurological surgery who is leading the study. Current radiation protocols for breast cancer, however, can be long and uncomfortable. Shorter courses treating smaller breast volumes, called partial breast irradiation, have shown considerable promise in clinical studies, he said. The most common partial breast irradiation approach, brachytherapy, requires a catheter implant via a surgical procedure. Another method delivers the treatment using conventional radiotherapy equipment but may lead to less-pleasing cosmetic results.
Dr. Wiginton described her first CyberKnife session as painless. Though a bit tired, she said the treatment was not uncomfortable and she spent most of the time listing to music on her iPod.
"You don't have to worry about moving too much, because you are put into a mold," she said, referring to a special padded bed she rested on during the procedure.
The trial's protocol is being carried out in conjunction with experts in the UT Southwestern Center for Breast Care at the Harold C. Simmons Cancer Center, the only National Cancer Institute-designated center in North Texas.
Patients preparing for CyberKnife radiation treatments have minute gold seed markers called fiducials implanted around the affected breast tissue. The CyberKnife's image-guided system tracks the fiducials to deliver radiation to the area, including moving with each breath taken by the patient.
Instead of standard radiation therapy systems that require heavy equipment with very limited maneuverability and beam direction, CyberKnife uses a lighter linear accelerator on a robotic arm to focus multiple beams of radiation with a millimeter precision, while leaving surrounding healthy tissue unharmed.
"The impetus for this protocol is to avoid that invasiveness while still achieving excellent cosmetic results," said Dr. Timmerman, referring to the typical brachytherapy procedure. "This gives the same amount of radiation, but in a noninvasive way. Each [CyberKnife-delivered] beam is very weak, so it causes very little entry damage. It will move around to 200 different positions."
Qualified participants must have localized early-stage breast cancer, must have successfully underwent a lumpectomy and be at least 18 years old. Patients will be evaluated over the next 10 years to check if they remain cancer-free, for potential cosmetic changes in the breast and any unanticipated effects that may develop from radiation treatment.
Dr. Wiginton, referred for the study by Dr. Dan Garwood, associate professor of radiation oncology, said she hopes the procedure will be successful and offer new radiation therapy options for breast-cancer patients.
Because heart disease ran her family, traditional radiation therapy wasn't a good choice for Dr. Wiginton due to potential damage to surrounding tissues, including the heart. CyberKnife's precision greatly lessened that risk.
"If they're willing to use it on brain cancer, I think it's a fairly safe bet to use in a breast," Dr. Wiginton said.
INFORMATION:
Visit www.utsouthwestern.org/simmons-cancer-center, or call Laurin Loudat at 214-648-1631 to learn more about this UT Southwestern clinical trial in radiation oncology.
This news release is available on our World Wide Web home page at
http://www.utsouthwestern.edu/home/news/index.html
To automatically receive news releases from UT Southwestern via e-mail,
subscribe at www.utsouthwestern.edu/receivenews
END
Chemical releases, suicide bombers, air and subsurface threats: the U.S. Secret Service needs to be prepared to handle these real-life incidents. Training to respond to such incidents, however, has been more theoretical than practical.
Now, with help from the Department of Homeland Security (DHS) Science & Technology Directorate (S&T), the Secret Service is giving training scenarios a high-tech edge: moving from static tabletop models to virtual kiosks with gaming technology and 3D modeling.
For the past 40 years, a miniature model environment called "Tiny Town" ...
Since 1965, the chances of dying early (under 75) are a fifth higher in the north of England than the south, finds a study published on bmj.com today.
An accompanying editorial says the north-south health divide is now at its widest for 40 years and warns that "the north is being decimated at the rate of a major city every decade."
The north-south health divide in England is well documented and has posed a public health challenge - as well as a political and economic challenge - to successive governments. From 2003 to 2010, the UK government had performance targets ...
Depression can be treated effectively with psychotherapy by mental health nurses with minimal training, according to new preliminary research findings.
The study, led by Durham University's Mental Health Research Centre, shows that patients with severe depression can be treated successfully with behavioural activation – a psychotherapy for depression – by non-specialist mental health staff which could potentially lead to considerable cost-savings for the NHS.
Currently, psychotherapies, such as behavioural activation, are delivered by specialist clinicians and therapists. ...
The genome of the Blackleg fungus, which causes the most damaging disease to canola crops worldwide, has been sequenced for the first time by a team of French and Australian scientists.
Professor Barbara Howlett from the School of Botany at the University of Melbourne, who led the Australian research team, said the discovery was a significant step towards controlling the rampant Blackleg disease.
"The 12,500 genes that constitute the genetic blue print for the fungus Leptosphaeria maculans have been identified and now can be mined to discover how this fungus causes ...
VIDEO:
Three snapshots of the 3-D structure of Mycobacterium tuberculosis' enzyme PriA are combined in this video to show the changes the enzyme is capable of undergoing.
Click here for more information.
In a paper published today in PNAS, scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, reveal new insights into the workings of enzymes from a group of bacteria including Mycobacterium tuberculosis, the bacterium that causes tuberculosis. ...
UPTON, NY - Scientists hoping to unravel the mystery of proton spin at the Relativistic Heavy Ion Collider (RHIC, http://www.bnl.gov/rhic/), a 2.4-mile-circumference particle accelerator at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, have a new tool at their disposal - the first to directly explore how quarks of different types, or "flavors," contribute to the overall spin of the proton. The technique, described in papers just published by RHIC's STAR and PHENIX collaborations in Physical Review Letters, relies on the measurement of particles called ...
Scientists today agree that there are five molecules that are known to affect or cause Alzheimer's disease, which plagues an estimated five million Americans. The potency of these molecules is linked to environmental factors such as diet and lifestyle.
Prof. Daniel Michaelson of Tel Aviv University's Department of Neurobiology at the George S. Wise Faculty of Life Sciences has illuminating news about one of these five molecules — APOE, created by the apolipoprotein E. gene found in all of our bodies.
Prof. Michaelson says APOE comes in two forms, a "good" APOE gene ...
This release is available in French.
Montreal, February 15, 2011 — For many women in violent relationships, leaving is not an option. Yet a woman's arsenal of defenses for resisting violence critically depends on her position within the family and community, according to new research from Concordia University published in the journal Review of Radical Political Economics.
"Women's resistance is often conceptualized only as exit, which is problematic," says study author Stephanie Paterson, a professor in the Concordia University Department of Political Science and ...
CHG cloths more effective in reducing risk for acquiring HAIs
Study shows 64 percent decreased risk of infection from MRSA or VRE
May be beneficial for both ICU and general medical unit patients
PROVIDENCE, R.I. – A new study from Rhode Island Hospital has found a reduced risk of hospital-acquired infections (HAI) when using two percent chlorhexidine gluconate (CHG) cloths for daily bathing instead of soap and water. The study found a 64 percent decrease in the risk of acquiring an infection from either methicillin-resistant Staphylococcus aureus (MRSA) or Vancomycin-resistant ...
The way the heart responds to an early beat is predictive of cardiac death, especially for people with no conventional markers of cardiovascular disease, according to new research from Washington University School of Medicine in St. Louis.
The conventional risk factors, such as high cholesterol, smoking, diabetes and high blood pressure, account for many but not all deaths from cardiovascular causes. As a result, doctors are always searching for better ways to identify patients at risk of cardiac death.
The new research indicates that an abnormal response to an early ...
